Compare VTEX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTEX | MLAB |
|---|---|---|
| Founded | 1999 | 1982 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 755.3M | 719.9M |
| IPO Year | 2019 | 1995 |
| Metric | VTEX | MLAB |
|---|---|---|
| Price | $3.60 | $131.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $5.97 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 651.9K | 100.2K |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | $12.78 | $6.07 |
| Revenue Next Year | $9.63 | $5.41 |
| P/E Ratio | ★ $43.33 | $271.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.84 | $66.52 |
| 52 Week High | $4.62 | $138.66 |
| Indicator | VTEX | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 58.39 |
| Support Level | $3.45 | $94.20 |
| Resistance Level | $3.74 | $132.70 |
| Average True Range (ATR) | 0.07 | 4.81 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 28.57 | 61.74 |
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.